Impact of calcified lesion on the intimal hyperplasia after implantation of drug eluting stent: An intravascular ultrasound study

National Medical Journal of China

Volumn 86, Issue 16, 2006, Pages 1118-1121

  Zhang, Rui Yan ^a   Shen, Wei Feng ^a   Zhang, Jian Sheng ^a   Yang, Zhen Kun ^a   Zhang, Qi ^a   Hu, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary angiography; Coronary diseases; Drug eluting stents; Tunica intima; Ultrasonography, interventional

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME;

AGED; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; STENTS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33745475284     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation, 2001,104:2007-2011.
2. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation, 2002,106:1949-1956.
3. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323.
4. Lemos PA, Hoye A, Goedhart, D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation, 2004,109:1366-1370.
5. Stone GW, St. Goar F, Fitzgerald P, et al. The optimal stent implantation trial: final core lab angiographic and ultrasound analysis (abstract). J Am Coll Cardiol, 1997;29:369.
6. Hoffmann R, Mintz GS, Pichard AD, Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study. Am J Cardiol, 1998,82:1168-1172.
7. Robert D S, Mark F. The Manual of Interventional Cardiology, 3rd Edition. Philadelphia: Physician's Press, 2001, 10-18.
8. Sonoda S, Morino Y, Ako J, et al. An optimal diagnostic threshold of minimum stent area to predict long-term stent patency following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS Trial. J Am Coll Cardiol,2003,41:80.
9. Takebayashi H, Mintz GS, Carlier SC. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation., 2004,110:3430-3434.
10. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol., 1994, 74:531-537.
11. Hong SJ, Kim MH, Ahn TH, et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in diabetic patients. Heart. 2006 31.
12. Colombo A, Hall P, Nakamura S. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation, 1995,91:1676-1688.
13. Painter JA, Mintz GS, Wong SC, et al. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol, 1995,75:398-400.
14. Hoffmann R, Haager P, Mintz GS, et al. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions: results of a randomized trial. Eur Heart J., 2001,22:2015-2024.